SCHEMBL23715872

SCHEMBL23715872

N=C(NC(O)C(NNOC1(c2ccc(Cl)cc2)CC1)c1cccc(Cl)c1)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
S1PR3 Q99500 14/20 0.40
S1PR4 O95977 7/20 0.40
S1PR2 O95136 2/20 0.40
S1PR1 P21453 6/20 0.38
S1PR5 Q9H228 2/20 0.33
OPRM1 P35372 2/20 0.33
OPRD1 P41143 2/20 0.33
OPRK1 P41145 2/20 0.33
OPRL1 P41146 2/20 0.33
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
F10 P00742 1/20 0.31
PRSS1 P07477 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
CCR1 P32246 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23715998 0.79 S1PR3 (0.42) S1PR3S1PR4S1PR2S1PR1S1PR5
SCHEMBL23715847 0.75 S1PR3 (0.42) S1PR3S1PR4S1PR2S1PR1S1PR5
SCHEMBL23716102 0.75 S1PR3 (0.40) S1PR3S1PR4S1PR2S1PR1S1PR5
SCHEMBL17663930 0.68 S1PR3 (0.47) S1PR3S1PR4S1PR2S1PR1MEN1
SCHEMBL23715931 0.67 S1PR3 (0.44) S1PR3S1PR4S1PR2S1PR1S1PR5
SCHEMBL17664015 0.65 S1PR3 (0.66) S1PR3S1PR4S1PR2S1PR1S1PR5
SCHEMBL17663900 0.64 S1PR3 (0.60) S1PR3S1PR4S1PR1S1PR5
SCHEMBL23716138 0.63 LMNA (0.34) S1PR3S1PR4CYP3A4CYP2C9CYP2C19
SCHEMBL13153641 0.60 S1PR3 (0.54) S1PR3S1PR4S1PR2S1PR1S1PR5
SCHEMBL28736369 0.59 LMNA (0.55) S1PR3S1PR1CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3209732-B1 SPHINGOSINE-1-PHOSPATE RECEPTOR MODULATORS FOR TREATMENT OF CARDIOPULMONARY DISORDERS SCRIPPS RESEARCH INST (US) 2021-08-04 EP disclosed